Terminology Service < Semantic Lookup Platform

All terms in NCIT

Label	Id	Description
East Indian Lemongrass Oil	NCIT_C107304	[The essential oil of Cymbopogon flexuosus. East Indian lemongrass oil has antifungal activity.]
Monoclonal Antibody 1.4 F(ab)	NCIT_C29197	[A nonspecific monoclonal antibody Fab fragment for murine leukemia virus (MuLV) 1.4. Monoclonal antibody 1.4 F(ab) has been used as a control in tests of specific monoclonal antibodies to cancers such as melanoma. (NCI04)]
Emu Oil	NCIT_C107305	[An oil rendered from the fat of the emu, Dromaius novaehollandiae. Emu oil is used for its anti-inflammatory and wound healing properties.]
Monoclonal Antibody 1F5	NCIT_C29198	[A murine monoclonal antibody directed against CD20, a cross-membrane ion channel phosphoprotein expressed by B cells, with potential antineoplastic activity. MOAB 1F5 binds to CD20, thereby directly inhibiting B-cell proliferation and differentiation. When cross-linked by secondary anti-mouse antibodies or Fc receptor-bearing cells, MOAB 1F5 may induce activation of B-cell protein tyrosine kinases, increases in B-cell intracellular calcium ion concentrations, and B-cell caspase activation, resulting in apoptosis of B cells expressing CD20. (NCI04)]
European Hazelnut Oil	NCIT_C107306	[The oil extracted from the nuts of Corylus avellana. Hazelnut oil is used as a food ingredient and flavoring.]
General Partnership	NCIT_C54133	[An association of two or more peoplecarrying on a business with the goal of earning a profit.]
Monoclonal Antibody 48.7	NCIT_C29199	[A mouse monoclonal antibody (MoAb) with proteoglycan antigen detection and binding activity. Hybridomas of SP2/0 mouse myeloma cells and mouse spleen cells are immunized with cultured human melanoma cells, and subsequently one of the hybridomas secreted MoAb 48.7. MoAb 48.7 is used for detection and binding to the proteoglycan antigen expressed on the cell surface of melanoma cells.]
Fenugreek Seed Oil	NCIT_C107307	[The oil pressed or distilled from the seeds of trigonella foenum gracecum. Fenugreek seed oil has activity as a phytoestrogen and topical activity as an antimicrobial agent.]
Joint Stock Company	NCIT_C54134	[A company which has some features of a corporation and some features of a partnership. The company sells fully transferable stock, but all shareholders have unlimited liability.]
Fish Liver Oil	NCIT_C107308	[The oil extracted from fish such as cod, salmon, and shark. Fish liver oils typically contain high levels of omega-3 fatty acids, EPA and DHA, and vitamins A and D. It is used as a dietary supplement.]
Genomic Data and Sample Coding Category	NCIT_C68754
Geranium Oil Algerian Type	NCIT_C107309	[The essential oil of Pelargonium graveolens. Geranium oil is used primarily for its aromatic properties.]
Identified Genomic Data and Samples	NCIT_C68755	[Identified data and samples are labelled with personal identifiers such as name or identification numbers (e.g., social security or national insurance number). As the samples and associated data are directly traceable back to the subject, it is possible to undertake actions such as sample withdrawal or the return of individual results. The use of identified data and samples allows for clinical monitoring, subject follow-up and the addition of new data. Identified data and samples coding offers privacy protection similar to general healthcare confidentiality in everyday medical practice. Identified data and sample coding are generally not considered appropriate for purposes of clinical trials in drug development. (ICH)]
Coded Data and Samples	NCIT_C68756	[Coded data and samples are labelled with at least one unique code and do not carry any personal identifiers.]
Single Coded Genomic Data and Samples	NCIT_C68757	[Single coded data and samples are labelled with a single code and do not carry any personal identifiers. It is possible to trace the data or samples back to the individual with the use of a single coding key. In general, the clinical investigator is responsible for maintaining the coding key. As the samples and associated data are indirectly traceable back to the subject via the coding key, it is possible to undertake actions such as sample withdrawal, or the return of individual results. The use of single coded data and samples allows for clinical monitoring, subject follow-up, or the addition of new data. Single coding is the current standard used in clinical research and offers additional safeguards to the subject identifiers compared to general healthcare confidentiality and privacy protection in everyday medical practice.]
Double Coded Genomic Data and Samples	NCIT_C68758	[Double coded data and samples are initially labelled with a single code and do not carry any personal identifiers. The data and samples are then relabelled with a second code, which is linked to the first code via a second coding key. It is possible to trace the data or samples back to the individual by the use of both coding keys. In general, the clinical investigator is responsible for maintaining the first coding key and does not have access to the second coding key. As the samples and associated data are indirectly traceable back to the subject via the use of both coding keys, it is possible to undertake actions such as sample withdrawal, or the return of individual results. The use of double coded data and samples allows for clinical monitoring, subject follow-up or the addition of new data. The use of the second code provides additional confidentiality and privacy protection for subjects over that of single coded. Access to both coding keys is needed to link any data or samples back to a subject identifier (ICH).]
Anonymised Genomic Data and Samples	NCIT_C68759	[Anonymised data and samples are initially single or double coded but the link between the subjects identifiers and the unique code(s) are subsequently deleted. Once the link has been deleted it is no longer possible to trace the data and samples back to the individual through the coding key(s). Anonymisation is intended to prevent subject re-identification. As anonymised samples and associated data are not traceable back to the subject it is not possible to undertake actions such as sample withdrawal, or the return of individual results. The use of anonymised data and samples does not allow for clinical monitoring, subject follow-up or the addition of new data. The deletion of the coding key(s) linking the data and samples to the subjects identifiers provides additional confidentiality and privacy protection over coded data and samples, as it prevents subject re-identification through the use of the coding key(s) (ICH).]
Anonymous Genomic Data and Samples	NCIT_C68760	[Anonymous data and samples are never labelled with personal identifiers and therefore there is no potential to trace back genomic data and samples to an individual subject. In some instances only limited clinical data is associated with anonymous samples. As anonymous samples and associated data are not traceable back to the subject, it is not possible to undertake actions such as sample withdrawal, or the return of individual results. The use of anonymous data and samples does not allow for clinical monitoring, subject follow-up, or the addition of new data.]
Pharmacogenetic Test	NCIT_C68761
Pharmacogenomic Test	NCIT_C68762